skip to main content

News and Events

Recent Releases

03/23/2017 - 12:00pm

A new approach to target an undruggable prostate cancer driver

When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.

03/20/2017 - 5:30pm

Revised understanding of graft-versus-host disease origins offers new direction for potential therapies

An international research team led by the University of Michigan Life Sciences Institute is changing the understanding of the key cellular and molecular events that trigger graft-versus-host disease, an often-fatal complication of bone marrow transplants.
03/02/2017 - 4:30pm

Study finds not all women get appropriate care for cervical cancer

Fewer than three out of five women with cervical cancer received guideline-based care, a new study finds. For black and Hispanic women, it’s just over half, which could help explain why cervical cancer outcomes tend to be worse for these women.

03/01/2017 - 2:00pm

Michigan Medicine opens first prostate cancer risk clinic in the nation

It’s well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations – along with a handful of others – and aggressive prostate cancer.
02/15/2017 - 11:15am

Looking beyond cancer cells to understand what makes breast cancer spread

A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It’s part of a well-known family of receptors for which promising inhibitors are being developed.

All Releases